HUP0104552A2 - Orális vakcina hasmenés ellen - Google Patents
Orális vakcina hasmenés ellenInfo
- Publication number
- HUP0104552A2 HUP0104552A2 HU0104552A HUP0104552A HUP0104552A2 HU P0104552 A2 HUP0104552 A2 HU P0104552A2 HU 0104552 A HU0104552 A HU 0104552A HU P0104552 A HUP0104552 A HU P0104552A HU P0104552 A2 HUP0104552 A2 HU P0104552A2
- Authority
- HU
- Hungary
- Prior art keywords
- cfa
- oral vaccine
- escherichia coli
- vaccine against
- against diarrhea
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title abstract 2
- 229940126578 oral vaccine Drugs 0.000 title abstract 2
- 108010001506 colonization factor antigens Proteins 0.000 abstract 5
- 102000009016 Cholera Toxin Human genes 0.000 abstract 2
- 108010049048 Cholera Toxin Proteins 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 231100000249 enterotoxic Toxicity 0.000 abstract 1
- 230000002242 enterotoxic effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A tal lm ny emberben hasmenést okozó, enterotoxikus Escherichia colielleni or lis vakcinakészítményre vonatkozik. A tal lm ny szerintikészítmény legal bb h romféle koloniz ciós faktor antigént (CFA)tartalmaz meghat rozott mennyiségben, péld ul fajt nként 100 és 300 mgk"z"tti mennyiségben, melyeket a hőérzékeny enterontoxin gént nemtartalmazó, el"lt Escherichia coli baktérium (LT-) CFA I, CFA II (CS1,CS2, illetve CS3) és CFA IV (CS4, CSS, illetve CS6) fehérjéi ltalalkotott csoportból v lasztunk ki. A készítmény ezen kívül meghatrozott mennyiségben, péld ul 0,5 és 2,0 mg k"z"tti mennyiségbentartalmazza a koleratoxin B-alegységét (CTB), valamint alkalmasvivőanyagot, péld ul PBS-t. A tal lm ny szerinti vakcin t mentesítikaz esetleges hőstabil enterotoxintól (ST). Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9804415A SE515285C2 (sv) | 1998-12-18 | 1998-12-18 | Oralt vaccin mot diarré |
| PCT/SE1999/002306 WO2000037106A1 (en) | 1998-12-18 | 1999-12-09 | Oral vaccine against diarrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0104552A2 true HUP0104552A2 (hu) | 2002-04-29 |
| HUP0104552A3 HUP0104552A3 (en) | 2002-08-28 |
Family
ID=20413742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0104552A HUP0104552A3 (en) | 1998-12-18 | 1999-12-09 | Oral vaccine against diarrhea |
Country Status (25)
| Country | Link |
|---|---|
| EP (2) | EP1140159A1 (hu) |
| JP (1) | JP2002532562A (hu) |
| KR (1) | KR20010101233A (hu) |
| CN (1) | CN1330552A (hu) |
| AP (1) | AP1426A (hu) |
| AU (1) | AU778223B2 (hu) |
| BR (1) | BR9916278A (hu) |
| CA (1) | CA2352309A1 (hu) |
| CZ (1) | CZ20011947A3 (hu) |
| EE (1) | EE200100309A (hu) |
| HR (1) | HRP20010433A2 (hu) |
| HU (1) | HUP0104552A3 (hu) |
| ID (1) | ID29857A (hu) |
| IL (1) | IL143808A0 (hu) |
| IS (1) | IS5967A (hu) |
| MX (1) | MXPA01006200A (hu) |
| NO (1) | NO20012889D0 (hu) |
| NZ (1) | NZ527559A (hu) |
| OA (1) | OA11729A (hu) |
| PL (1) | PL198438B1 (hu) |
| SE (1) | SE515285C2 (hu) |
| TR (1) | TR200101542T2 (hu) |
| WO (1) | WO2000037106A1 (hu) |
| YU (1) | YU41701A (hu) |
| ZA (1) | ZA200104362B (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2437899C (en) * | 2001-02-13 | 2012-05-15 | Gregory M. Glenn | Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea |
| GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
| EP1543836A1 (en) * | 2003-12-17 | 2005-06-22 | Berna Biotech AG | Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| MX2009011495A (es) * | 2007-04-24 | 2010-02-15 | Celldex Therapeutics Inc | V cholerae que sobreexpresa la subunidad b de la toxina del colera recombinante y que presenta doble inmunogenicidad. |
| JP5985643B2 (ja) * | 2011-09-12 | 2016-09-06 | スカンジナビアン バイオファーマ ホールディング アーベー | 細胞表面上におけるｅｔｅｃｃｓ６抗原の提示を増大させるための方法およびその得られる産物 |
| CA2846354C (en) * | 2011-09-12 | 2023-04-25 | Scandinavian Biopharma Holding Ab | Vaccine for protection against etec-induced diarrhea comprising dmlt |
| RU2753410C2 (ru) * | 2020-01-14 | 2021-08-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кубанский государственный аграрный университет имени И.Т. Трубилина" | Способ получения анатоксин-вакцины против эшерихиоза животных |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9100556D0 (sv) * | 1991-02-26 | 1991-02-26 | Holmgren Jan | Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans |
-
1998
- 1998-12-18 SE SE9804415A patent/SE515285C2/sv not_active IP Right Cessation
-
1999
- 1999-12-09 HU HU0104552A patent/HUP0104552A3/hu unknown
- 1999-12-09 ID IDW00200101304A patent/ID29857A/id unknown
- 1999-12-09 JP JP2000589216A patent/JP2002532562A/ja not_active Withdrawn
- 1999-12-09 EE EEP200100309A patent/EE200100309A/xx unknown
- 1999-12-09 IL IL14380899A patent/IL143808A0/xx not_active IP Right Cessation
- 1999-12-09 WO PCT/SE1999/002306 patent/WO2000037106A1/en not_active Application Discontinuation
- 1999-12-09 EP EP99964847A patent/EP1140159A1/en not_active Withdrawn
- 1999-12-09 MX MXPA01006200A patent/MXPA01006200A/es not_active IP Right Cessation
- 1999-12-09 PL PL348257A patent/PL198438B1/pl unknown
- 1999-12-09 OA OA1200100151A patent/OA11729A/en unknown
- 1999-12-09 AU AU30889/00A patent/AU778223B2/en not_active Ceased
- 1999-12-09 YU YU41701A patent/YU41701A/sh unknown
- 1999-12-09 EP EP04010662A patent/EP1444987A3/en not_active Withdrawn
- 1999-12-09 NZ NZ527559A patent/NZ527559A/en unknown
- 1999-12-09 TR TR2001/01542T patent/TR200101542T2/xx unknown
- 1999-12-09 KR KR1020017007484A patent/KR20010101233A/ko not_active Application Discontinuation
- 1999-12-09 CZ CZ20011947A patent/CZ20011947A3/cs unknown
- 1999-12-09 BR BR9916278-4A patent/BR9916278A/pt not_active Application Discontinuation
- 1999-12-09 CN CN99814553A patent/CN1330552A/zh active Pending
- 1999-12-09 CA CA002352309A patent/CA2352309A1/en not_active Abandoned
- 1999-12-09 AP APAP/P/2001/002174A patent/AP1426A/en active
-
2001
- 2001-05-28 ZA ZA200104362A patent/ZA200104362B/en unknown
- 2001-06-08 HR HR20010433A patent/HRP20010433A2/hr not_active Application Discontinuation
- 2001-06-12 NO NO20012889A patent/NO20012889D0/no not_active Application Discontinuation
- 2001-06-13 IS IS5967A patent/IS5967A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL143808A0 (en) | 2002-04-21 |
| EP1444987A3 (en) | 2005-12-21 |
| PL198438B1 (pl) | 2008-06-30 |
| KR20010101233A (ko) | 2001-11-14 |
| MXPA01006200A (es) | 2002-04-17 |
| NZ527559A (en) | 2005-01-28 |
| IS5967A (is) | 2001-06-13 |
| OA11729A (en) | 2005-05-12 |
| CA2352309A1 (en) | 2000-06-29 |
| ID29857A (id) | 2001-10-18 |
| SE515285C2 (sv) | 2001-07-09 |
| EP1444987A2 (en) | 2004-08-11 |
| WO2000037106A1 (en) | 2000-06-29 |
| EP1140159A1 (en) | 2001-10-10 |
| TR200101542T2 (tr) | 2001-10-22 |
| ZA200104362B (en) | 2002-01-14 |
| SE9804415D0 (sv) | 1998-12-18 |
| HRP20010433A2 (en) | 2002-06-30 |
| YU41701A (sh) | 2005-07-19 |
| NO20012889L (no) | 2001-06-12 |
| CZ20011947A3 (cs) | 2001-12-12 |
| JP2002532562A (ja) | 2002-10-02 |
| BR9916278A (pt) | 2001-09-04 |
| AU778223B2 (en) | 2004-11-25 |
| AP1426A (en) | 2005-06-06 |
| PL348257A1 (en) | 2002-05-20 |
| EE200100309A (et) | 2002-08-15 |
| AU3088900A (en) | 2000-07-12 |
| NO20012889D0 (no) | 2001-06-12 |
| SE9804415L (sv) | 2000-06-19 |
| CN1330552A (zh) | 2002-01-09 |
| HUP0104552A3 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO922772D0 (no) | Siloxankopolymerer som oppviser alkenylgrupper, og fremstilling og anvendelse av siloxankopolymerene | |
| TW233242B (hu) | ||
| DE69434136D1 (de) | Dolastatin-derivate | |
| UA32525C2 (uk) | Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення | |
| CY1107276T1 (el) | Μεταλλαγμενη ολοτοξινη χολερας ως ενα ανοσοενισχυτικο | |
| CY1105399T1 (el) | Μεθοδος επιλεκτικης υποκαταστασεως των ταξανων | |
| NO951198L (no) | Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene | |
| ES2244617T3 (es) | Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados. | |
| HUP0104552A2 (hu) | Orális vakcina hasmenés ellen | |
| DK1112747T3 (da) | Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller | |
| DK0626452T3 (da) | Vaccine mod infektion af Streptococcus suis | |
| CY1105459T1 (el) | Συνθεσεις που πepιεχουν εποθιλονες και η χρηση τους για τη θepαπεια του καρκινοειδους συνδρομου | |
| SE9101838L (sv) | Nya polypeptider vilka kan utvinnas fraan tunntarmen och deras anvaendning | |
| ES2194841T3 (es) | Procedimiento de produccion de vacunas bacterianas gram negativas. | |
| NZ295238A (en) | Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase | |
| KR100400352B1 (hu) | ||
| CY1105345T1 (el) | Φαινυλαλκινια | |
| IL98479A0 (en) | Hexahydroazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| BRPI0309001A2 (pt) | bactérias gram-negativas atenuadas | |
| AU8445791A (en) | Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria | |
| ATE133977T1 (de) | Vinyloxygruppen aufweisende siloxancopolymere, deren herstellung und verwendung | |
| DE50008200D1 (de) | Silikonhaltige Zusammensetzungen für die Behandlung von Wollematerialien | |
| ES2087535T3 (es) | Procedimiento para la preparacion enzimatica de macrolactona. | |
| FI971402A0 (fi) | Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi | |
| SE9604322D0 (sv) | Bacterial antigens and vaccine compositions II |